Effects of OROS® methylphenidate (MPH) treatment on behavior and performance in children with ADHD with and without comorbid learning disability

被引：0
|
作者：
Starr, H. Lynn [1 ]
Armstrong, Robert [1 ]
Damaraju, C., V [2 ]
Ascher, Steve [2 ]
机构：
[1] Johnson & Johnson, Psychiat, New Brunswick, NJ USA
[2] Johnson & Johnson, Biostat, New Brunswick, NJ USA
来源：
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2011年 / 20卷 / 01期
关键词：
D O I：
暂无
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
P01-36
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy
    Kesic, A.
    Lakic, A.
    Dronjak, D.
    Stupar, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S420 - S421
  • [2] The incidence of personality disorder in adults with ADHD, and the effects on response to treatment with OROS methylphenidate (OROS MPH)
    Casciol, Carissa
    Sassoon, Rachel E.
    Carroll-Sharpe, Abigail
    Essick, Gregory K.
    Baranek, Grace T.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 245S - 245S
  • [3] Assessing Personality Disorder in Adults With ADHD, and its Effects on Response to Treatment with OROS® Methylphenidate (OROS® MPH)
    Robison, Reid
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Gale, Phillip
    Williams, Erika D.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 632 - 632
  • [4] Methylphenidate in Children With ADHD With or Without Learning Disability
    Williamson, David
    Murray, Desiree W.
    Damaraju, C. V.
    Ascher, Steve
    Starr, H. Lynn
    JOURNAL OF ATTENTION DISORDERS, 2014, 18 (02) : 95 - 104
  • [5] The Impact of Age on Treatment Response With OROS® Methylphenidate (MPH) in Adults With ADHD
    Starr, Harriet L.
    Goodman, David W.
    Damaraju, Chandrasekhar Rao V.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 637 - 637
  • [6] Effects and side effects of Concerta methylphenidate (MPH) in children with ADHD and comorbid internalizing symptoms
    Stein, MA
    Seymour, KE
    Black, DO
    Sarampote, CS
    Robb, A
    Conlon, C
    Efron, LA
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [7] Combined OROS MPH and atomoxetine in ADHD treatment in children
    Wilens, Timothy
    Hammerness, Paul
    Spencer, Thomas J.
    Whitley, Julia
    Traina, Stephanie
    Santry, Alison
    Biederman, Joseph
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 660 - 661
  • [8] OROS MPH treatment effects between girls and boys with ADHD
    Starr, Harriette L.
    Zhang, Huabin
    Kemner, Jason E.
    Cooper, Kimberly M.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05): : 442 - 442
  • [9] Time Course of Treatment Effect of OROS® Methylphenidate in Children With ADHD
    Armstrong, Robert B.
    Damaraju, C. V.
    Ascher, Steve
    Schwarzman, Lesley
    O'Neill, James
    Starr, H. Lynn
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (08) : 697 - 705
  • [10] Evaluation of efficacy and safety of OROS® methylphenidate HCl (MPH) extended-release tablets, methylphenidate tid, and placebo in children with ADHD
    Wolraich, ML
    PEDIATRIC RESEARCH, 2000, 47 (04) : 36A - 36A
12345